Literature DB >> 1502154

Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is an hepatic receptor for tissue-type plasminogen activator.

G Bu1, S Williams, D K Strickland, A L Schwartz.   

Abstract

Tissue-type plasminogen activator (t-PA), a serine protease that catalyzes the initial and rate-limiting step in the fibrinolytic cascade, is cleared rapidly in vivo by the liver. Using chemical crosslinking, we have recently identified a plasminogen-activator inhibitor type 1 (PAI-1)-independent t-PA clearance receptor on rat hepatoma MH1C1 cells with a relative molecular mass of approximately 500 kDa. Another recently identified membrane receptor, low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor (LRP/alpha 2MR), was also detected on MH1C1 hepatoma cells by using immunoprecipitation with anti-LRP/alpha 2MR antibody. When analyzed by SDS/PAGE, we found the t-PA receptor identified on MH1C1 cells comigrated with the large subunit of LRP/alpha 2MR. The t-PA receptor was immunoprecipitated by an anti-LRP/alpha 2MR antibody after chemical crosslinking of specifically bound 125I-labeled t-PA to its receptor. Through chemical crosslinking studies, we found that t-PA and methylamine-activated alpha 2-macroglobulin could bind to LRP/alpha 2MR simultaneously without competing with one another for binding, suggesting that the two ligands bound to two independent sites on the LRP/alpha 2MR molecule. Furthermore, a 39-kDa protein, which modulates ligand binding to LRP/alpha 2MR, was also found to inhibit t-PA binding to its receptor. These data thus show that the t-PA clearance receptor identified on MH1C1 hepatoma cells is LRP/alpha 2MR.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1502154      PMCID: PMC49723          DOI: 10.1073/pnas.89.16.7427

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

Review 1.  Strategies for the improvement of thrombolytic agents.

Authors:  H R Lijnen; D Collen
Journal:  Thromb Haemost       Date:  1991-07-12       Impact factor: 5.249

2.  Clearance of tissue plasminogen activator by mannose and galactose receptors in the liver.

Authors:  B Smedsrød; M Einarsson
Journal:  Thromb Haemost       Date:  1990-02-19       Impact factor: 5.249

3.  Sequence identity between the alpha 2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor.

Authors:  D K Strickland; J D Ashcom; S Williams; W H Burgess; M Migliorini; W S Argraves
Journal:  J Biol Chem       Date:  1990-10-15       Impact factor: 5.157

4.  Primary structure of alpha 2-macroglobulin receptor-associated protein. Human homologue of a Heymann nephritis antigen.

Authors:  D K Strickland; J D Ashcom; S Williams; F Battey; E Behre; K McTigue; J F Battey; W S Argraves
Journal:  J Biol Chem       Date:  1991-07-15       Impact factor: 5.157

5.  39-kDa protein modulates binding of ligands to low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor.

Authors:  J Herz; J L Goldstein; D K Strickland; Y K Ho; M S Brown
Journal:  J Biol Chem       Date:  1991-11-05       Impact factor: 5.157

6.  Analysis of ligand recognition by the purified alpha 2-macroglobulin receptor (low density lipoprotein receptor-related protein). Evidence that high affinity of alpha 2-macroglobulin-proteinase complex is achieved by binding to adjacent receptors.

Authors:  S K Moestrup; J Gliemann
Journal:  J Biol Chem       Date:  1991-07-25       Impact factor: 5.157

7.  Binding of plasminogen activator inhibitor type-1 to extracellular matrix of Hep G2 cells. Evidence that the binding protein is vitronectin.

Authors:  D A Owensby; P A Morton; T C Wun; A L Schwartz
Journal:  J Biol Chem       Date:  1991-03-05       Impact factor: 5.157

8.  The receptor for tissue plasminogen activator (t-PA) in complex with its inhibitor, PAI-1, on human hepatocytes.

Authors:  L R Wing; B Bennett; N A Booth
Journal:  FEBS Lett       Date:  1991-01-14       Impact factor: 4.124

9.  Proteolytic processing of the 600 kd low density lipoprotein receptor-related protein (LRP) occurs in a trans-Golgi compartment.

Authors:  J Herz; R C Kowal; J L Goldstein; M S Brown
Journal:  EMBO J       Date:  1990-06       Impact factor: 11.598

10.  Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor.

Authors:  J Herz; U Hamann; S Rogne; O Myklebost; H Gausepohl; K K Stanley
Journal:  EMBO J       Date:  1988-12-20       Impact factor: 11.598

View more
  79 in total

1.  Novel plasminogen activator inhibitor-1-derived peptide protects against impairment of cerebrovasodilation after photothrombosis through inhibition of JNK MAPK.

Authors:  William M Armstead; John Riley; J Willis Kiessling; Douglas B Cines; Abd Al-Roof Higazi
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-06-10       Impact factor: 3.619

Review 2.  Lipoprotein receptors--an evolutionarily ancient multifunctional receptor family.

Authors:  Marco Dieckmann; Martin Frederik Dietrich; Joachim Herz
Journal:  Biol Chem       Date:  2010-11       Impact factor: 3.915

3.  Combination therapy with glucagon and a novel plasminogen activator inhibitor-1-derived peptide enhances protection against impaired cerebrovasodilation during hypotension after traumatic brain injury through inhibition of ERK and JNK MAPK.

Authors:  William M Armstead; John Riley; Douglas B Cines; Abd Al-Roof Higazi
Journal:  Neurol Res       Date:  2012-05-30       Impact factor: 2.448

4.  Role of tissue plasminogen activator receptor LRP in hippocampal long-term potentiation.

Authors:  M Zhuo; D M Holtzman; Y Li; H Osaka; J DeMaro; M Jacquin; G Bu
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

5.  Tissue Plasminogen Activator: Side Effects and Signaling.

Authors:  Ling Lin; Kebin Hu
Journal:  J Drug Des Res       Date:  2014-09-25

6.  The NMDA receptor functions independently and as an LRP1 co-receptor to promote Schwann cell survival and migration.

Authors:  Elisabetta Mantuano; Michael S Lam; Masataka Shibayama; W Marie Campana; Steven L Gonias
Journal:  J Cell Sci       Date:  2015-08-13       Impact factor: 5.285

7.  tPA contributes to impairment of ATP and Ca sensitive K channel mediated cerebrovasodilation after hypoxia/ischemia through upregulation of ERK MAPK.

Authors:  William M Armstead; John Riley; Douglas B Cines; Abd Al-Roof Higazi
Journal:  Brain Res       Date:  2010-12-20       Impact factor: 3.252

8.  Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein mediate cerebral ischemia-induced nuclear factor-kappaB pathway activation.

Authors:  Xiaohui Zhang; Rohini Polavarapu; Hua She; Zixu Mao; Manuel Yepes
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

9.  Regulation of macrophage alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein by lipopolysaccharide and interferon-gamma.

Authors:  J LaMarre; B B Wolf; E L Kittler; P J Quesenberry; S L Gonias
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

10.  Demonstration by fluorescence resonance energy transfer of two sites of interaction between the low-density lipoprotein receptor-related protein and the amyloid precursor protein: role of the intracellular adapter protein Fe65.

Authors:  A Kinoshita; C M Whelan; C J Smith; I Mikhailenko; G W Rebeck; D K Strickland; B T Hyman
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.